Subscribe to our Newsletters !!

    Hepatitis B Virus

    UCL researchers distinguish new immunotherapy to battle hepatitis B infection

    Researchers at UCL have identified a new immunotherapy to fight the hepatitis B virus (HBV), the most frequent cause of liver cancer in the world. The pioneering study used immune cells isolated directly from patient liver and tumour tissue, to demonstrate that targeting acyl-CoA:cholesterol acyltransferase (ACAT), an enzyme which helps to manage cholesterol levels in